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Abstract Kainate binding proteins (KBPs) from frog and gold- 
fish brain are glycosylated, integral membrane proteins. These 
KBPs are homologous (35-40%) to the C-terminal half of AMPA 
and kainate receptors which have been shown to form glutamate- 
gated ion channels. We report here that the frog KBP has three 
functional N-glycosylation sites. Of particular interest, Asn-265, 
a residue located between two putative membrane spanning re- 
gions of the frog KBP, is a functional N-glycosylation site. A 
mutation of Ser-267 to Gly renders this site non-functional as 
shown using an in vitro translation system and by transient ex- 
pression in human embryonic kidney (HEK 293) cells. The mu- 
tant receptor protein ($267G), when expressed in HEK cells, 
binds kainate with high affinity (K d = 16 nM). These results fur- 
ther support a topology with three transmembrane segments for 
KBPs and, by sequence homology, for glutamate-gated ion chan- 
nels. 
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1. Introduction 
Glutamate receptors are the major excitatory neurotransmit- 
ter receptors in the vertebrate central nervous system. The 
ionotropic glutamate receptors (iGluRs, ligand-gated ion chan- 
nels) can be divided into AMPA (~-amino-3-hydroxy-5-meth- 
ylisoxazole-propionate), kainate and NMDA (N-methyl-o-as- 
partate) subtypes based on pharmacological data [1]. Molecular 
cloning and functional analysis have yielded awealth of knowl- 
edge about iGluRs [24]. Functional ion channels are formed 
by subunits of 100 kDa either alone or in various combinations. 
AMPA receptors are formed by GluR1-GluR4 subunits, ka- 
inate receptors are formed by GluR5-GIuR7 and KA-1 and 
KA-2 subunits. NMDA receptors are formed by NR1 and 
NR2A-2D. In addition to these functional iGluRs from various 
species, high affinity kainate binding proteins have been puri- 
fied and the cDNA cloned from several nonmammalian verte- 
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Abbreviations." AMPA, ~-amino-3-hydroxy-5-methylisoxazolepropion- 
ate; Endo H, endo-fl-N-acetylglucosaminidase H; iGluR, ionotropic 
glutamate r ceptor; KBP, kainate binding protein; FKBP, frog kainate 
binding protein; GFKAR~, 45 kDa kainate receptor subunit from 
goldfish brain; GFKARfl, 41 kDa kainate receptor subunit from gold- 
fish brain; HEK, human embryonic kidney; NMDA, N-methyl-D-as- 
partate; SDS-PAGE, sodium dodecylsulphate polyacrylamide g lelec- 
trophoresis; TM, transmembrane domain; TMI, TMII, TMIII, TMIV, 
first, second, third and fourth putative transmembrane domain as orig- 
inally defined by hydropathy plots. 
brate species (e.g. fish, flog, bird, [5-7]), these proteins (40-50 
kDa) are homologous (3540%) to the C-terminal half of sub- 
units (100 kDa) of AMPA and kainate receptors. 
iGluRs have long been thought o be structurally similar to 
other ligand-gated ion channels having four transmembrane 
segments with the ligand binding domain in the N-terminal 
extracellular region (e.g. nicotinic acetylcholine receptors, 
GABA receptors, glycine receptors). This long-held, pervasive 
assumption has recently been questioned [8], largely due to the 
study of the transmembrane topology of various subtypes of 
iGluRs. Recent evidence has indicated that previously pro- 
posed topological models with four or five transmembrane 
segments are incorrect. Based on our topological analysis of 
goldfish kainate receptors, including the study of native and 
engineered N-glycosylation sites and proteolytic patterns of 
GFKAR~ and GFKARfl, we have proposed a topological 
model with three transmembrane s gments for kainate recep- 
tors [5,9]. An identical model was subsequently proposed based 
on the study of engineered N-glycosylation sites in GluRI [10] 
and constructs of epitope-tagged GIuR3 [11]. This 3-TM model 
has provided important insight into the modular structure of 
iGluRs and will serve as a framework for future detailed struc- 
ture-function analyses. 
In the present study, we analyze the N-glycosylation of the 
frog KBP in both an in vitro translation/membrane transloca- 
tion system and an HEK cell expression system. We provide 
further evidence in support of the 3-TM model by identifying 
a native and functional N-glycosylation site (Asn-265) of frog 
KBP. This is the first demonstration of a native glycosylation 
site in the region of iGluRs proposed to be cytoplasmic in 
models with four and five transmembrane s gments. 
2. Material and methods 
2.1. Materials 
[3H]Kainic acid (60 Ci/mmol) was purchased from Dupont NEN. 
e-[35S]Methionine (1100 Ci/mmol) was purchased from Amersham 
Corp. Autoradiography enhancer INTENSIFY was purchased from 
DuPont NEN. Endo-fl-N-acetylglucosaminidase H (Endo H) and N- 
glycosidase F were obtained from Boehringer-Mannheim. The mono- 
clonal antibody KAR-B1 was a gift from Dr. David R. Hampson 
(Univ. Toronto). 
2.2. Site-directed mutagenesis and truncation mutant 
(A) The $267G mutation was prepared using PCR. The T7 primer 
and an antisense oligonucleotide (5'-CCGAATTCTTAAAGAAATT- 
TAAAGTGGCAGAG-3') were paired to amplify a fragment of 960 bp 
from frog KBP cDNA in pBluescript. The PCR fragment was digested 
with XbaI and EcoRl and was used to replace the corresponding frag- 
ment of wild-type frog KBP cDNA. The mutation was confirmed by 
DNA sequencing. (B) cDNA encoding the N-terminal i 18 amino acid 
residues of frog KBP was subcloned into pcDNAII vector (Invitrogen). 
An antisense oligonucleotide (27-mer, 5"-GCGCTCGAG(XhoI 
site)TTA(stop codon)CATTGTTAAAGGTGC-3') was paired with a 
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T7 (pBluescript) primer to amplify a 480 bp cDNA fragment from the 
frog KBP cDNA clone (in pBluescript) by PCR. This PCR fragment 
was digested with Spe! and XhoI, then subcloned into pcDNAII vector 
(Invitrogen). This construct was termed N118(VKBp~. 
2.3. In vitro translation and transloeation 
Promega's TNT coupled rabbit reticulocyte lysate system was used 
as described previously [5]. T7 polymerase was used to transcribe frog 
KBP and KBP(S267G) mutant cDNA in pBluescript vector. SP6 
polymerase was used to transcribe GFKAR~ cDNA and the construct 
N 118~Fr~Bm in pcDNAII vector. For N-glycosylation, canine pancreatic 
rnicrosomal membranes (Promega) were added to the translation sys- 
tem as indicated previously [5]. The translational efficiency of frog KBP 
and FKBP(S267G) cDNAs is about 5-fold lower than GFKARc~ and 
GFKARfl cDNAs. To load a similar amount of [~SS]Met-labeled pro- 
tein, samples of frog KBP and FKBP(S267G), translated in the pres- 
ence of microsomes, were centrifuged, and the pellets (MM fractions) 
were then resuspended in a 5-fold smaller volume. Samples were ana- 
lyzed on SDS-polyacrylamide gels (8% or 14%). Gels were treated with 
the enhancer and [3SS]methionine-labeled bands were visualized with 
fluorography on Kodak XAR film. 
2.4. Expression in cultured HEK 293 cells 
Both frog KBP and KBP(S267G) mutant cDNA inserts (1.6 kb, with 
XbaI and XhoI ends) were subcloned from pBluescript into an expres- 
sion vector, pRBG4 [12]. HEK 293 cells (a transformed human embry- 
onic kidney cell line) grown to 6 × 105 cells/10-cm dish were transfected 
by these expression constructs (20/tg plasmid DNA/dish) using the 
calcium phosphate precipitation method [12]. HEK 293 cell membranes 
were prepared 48 h after transfection asdescribed previously [9]. Mem- 
brane pellets from each dish were resuspended in 0.5 ml of 1 mM PMSF 
and stored at -20°C. 
2.5. Western blotting and gel electrophoresis 
As described previously [9] samples of the transfected HEK 293 cell 
membrane preparations were solubilized in SDS loading buffer (8% 
fl-mercaptoethanol) andseparated by 10% SDS-polyacryamide gelelec- 
trophoresis. Proteins were electrophoretically transferred from the gel 
to Immobilon-P membrane (Millipore Corp.). The membrane was blot- 
ted sequentially b  the monoclonal ntibody FKAR-BI and a second 
antibody (horseradish peroxidase-conjugated goat anti-mouse IgG). 
Proteins recognized by the rnAb FKAR-B I were visualized using Ren- 
aissance Chemiluminescence reagent (Dupont NEN). 
2.6. [SH]Kainate binding assay 
[3H]Kainate binding to transfected HEK 293 cell membrane prepara- 
tions was measured as described previously for membranes [13,14]. The 
additional presence of 100 ArM kainate in the assays defined nonspecific 
binding. 
3. Results 
Native frog KBP is a glycoprotein with an apparent molecu- 
lar mass of 48 kDa on SDS-PAGE [15-17]. The deduced se- 
quence of frog KBP cDNA indicates that there are two putative 
sequence y y - -  _ _  __  , y 
TMI TMII TMIII TMIV 
} LAOBP/~BP I K+chanrlel-Ilke I LAOBP/QBP I Regulato~--] 
Fig. 1. Schematic depiction of frog KBE The signal sequence and three 
proposed transmembrane segments (TMI, TMIII and TMIV) are 
shown as black boxes. The originally designated TMII (likely not a true 
transmembrane segment) is shown as a gray box. Three consensus 
N-glyeosylation sites (Asn-X-Ser/Thr) are shown with a ~ ; a fourth site 
which has a proline following the Asn-X-Ser/Thr motif is indicated with 
a [. Two regions of frog KBP homologous to the bacterial periplasmic 
amino acid binding proteins are indicated as LAOBP/QBP (lysine-, 
arginine- and ornithine-binding protein and glutamine-binding protein) 
regions. The region comprising TMI to TMIII is homologous to the 
channel pore of K ÷ channels [8]. 
A B 
GFKARet FKBP FKBP(S267G) ctr N1181~Bm 
1 2 3 4 5 6 7 8 9 10 I 2 3 
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- 15kDa 
MM + + + + + + + + + 
Endo H + + + + 
Fig. 2. (A) In vitro translation and glycosylation of goldfish and frog 
kainate binding proteins and the frog KBP(S267G) mutant. Samples 
were separated on 8% SDS-PAGE. Note that an endogenous 52 kDa 
band is visible (lane 10) in a 5-fold concentrated control sample (e.g. 
no eDNA template). (B) In vitro translation and glycosylation of the 
N-terminal 118 amino acids of frog KBP. Samples were separated on 
14% SDS-PAGE. Microsomal membranes are noted with MM. The 
glycosylated species are indicated by an asterisk. 
N-glycosylation sites (N61YT and N81WS) in the N-terminal 
extracellular region preceding TMI  ([6]; Fig. 1). Our proposed 
3-TM model [5,8] would suggest hat in addition to these two 
sites, N265SS may also be a functional N-glycosylation site. 
This site is 35 residues downstream from the C-terminal end of 
the proposed TMII. A coupled in vitro translation/membrane 
translocation system was used to determine the number of the 
core oligosaccharide chains transferred to the newly synthe- 
sized frog KBP. We have previously used this system to charac- 
terize the N-glycosylation sites in goldfish kainate receptors 
(GFKARc~ and GFKARfl ;  [5,9]), which are 55% homologous 
to frog KBP. GFKARa has three functional N-glycosylation 
sites. Each uniform core oligosaccharide chain transferred from 
a lipid donor to acceptor Asn residues has a apparent mass of 
3 kDa [18]. Frog KBP translated in vitro in the absence of 
rnicrosomes was about 3 kDa larger than non-glycosylated 
GFKARc~ (44 kDa vs. 41 kDa; Fig. 2, lane 4 vs. lane 1), 
consistent with the fact that frog KBP is 30 residues longer than 
GFKAR~ [5,6]. In the presence of microsomes, GFKARa 
translated in vitro exhibited two glycosylated bands, corre- 
sponding to species with two and three core oligosaccharide 
chains [9]. Whereas, in the presence of microsomes, frog KBP 
has two glycosylated species, the fully glycosylated form is 
approximately 9 kDa larger than the non-glycosylated form 
(Fig. 2, lanes 4 and 5), indicating the presence of three func- 
tional sites for N-glycosylation. In contrast, the KBP(S267G) 
mutant, in which the N265SS site has been changed into a 
non-consensus sequence, has only two attached oligosac- 
charide chains when translated in the presence of microsomes 
(Fig. 2, lane 8). Therefore, Asn-265 is a functional N-glycosyl- 
ation site in this in vitro translation/translocation experiment, 
indicating that sequence surrounding Asn265 is translocated 
into the lumen of microsomes (equivalent to the rough endo- 
plasmic reticulum). 
With this in vitro translation system, we found that the trans- 
lational efficiency of frog KBP and KBP(S267G) cDNA is 
about 5-fold lower than GFKARc~ and GFKARf l  eDNA. This 
may be due to a number of factors; for example, the transla- 
tional initiation could be affected by structural features of the 
mRNA [19,20]. Apparently associated with this relatively low 
efficiency of the translation initiation site of frog KBP cDNA, 
a second band was consistently observed (approximately 3 kDa 
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GFKARct GFKAR~5 FKBP FKBP(S267G) 
1 2 3 4 5 6 7 8 
-43 kDa 
N-Glycosidase F: + + + + 
Fig. 3. Immunoblotting of kainate binding proteins expressed in HEK 
293 cells. Samples (10/,tl) of a resuspended transfected cell membrane 
pellet (the pellet of each 10 cm dish is resuspended in 0.5 ml of 1 mM 
PMSF), with or without N-glycosidase F treatment, were separated on 
10% SDS-PAGE (under educing conditions). Receptor proteins were 
recognized by the specific monoclonal antibody (mAb KAR-B1), and 
visualized by chemiluminescence. 
smaller than the major 43 kDa band, see Fig. 2A, lanes 4 and 
7). This second band may be the product of translational initi- 
ation at a second site, which may be an internal AUG or a 
non-AUG codon [21]. 
The most likely candidates for the additional two functional 
glycosylation sites left in frog KBP(S267G) were N61YT and 
N81WS. To test this, a cDNA fragment encoding the N-termi- 
nal 118 amino acid residues of frog KBP was subcloned into 
the pcDNAII vector with a stop codon introduced at the end 
of this DNA fragment (N118~FKBp)). This region comprises the 
signal sequence (17 aa residues) and 101 amino acids of the 
N-terminal portion of the mature protein. In vitro translation 
of N118~vKap) in the absence of microsomes yielded a major 
species of 10 kDa (Fig. 2B, lane 1). In the presence of micro- 
somes, a major species of 15 kDa was produced (Fig. 2B, lane 
2), indicating a modification by glycosylation. This 15 kDa 
species was converted into 9 kDa species when treated with 
Endo H (Fig. 2B, lane 3), confirming that it was N-glycosylated. 
The 6 kDa difference in mobility is consistent with the attach- 
ment of two core oligosaccharide chains. The Endo H deglyco- 
sylated from (9 kDa) is slightly smaller than the product (10 
kDa) in the absence of microsomes (Fig. 2B, compare lane 3 
vs. lane 1), indicating the N-terminal signal sequence (17 aa) 
was cleaved upon translocation across the membrane of micro- 
somes. Therefore, N61YT and N81WS in the N-terminal ex- 
tracellular egion are functional glycosylation sites and are 
likely to be glycosylated in the native protein. 
Kainate receptors (GFKAR~, GFKARfl, frog KBP and the 
mutant FKBP(S267G)) were transiently expressed in HEK 293 
cells. Cell membrane preparations were analyzed by im- 
munoblotting using the monoclonal antibody KAR-B1, which 
was raised against frog KBP [16] and recognizes goldfish ka- 
inate receptors (GFKARct, 45 kDa, and GFKARfl, 41 kDa) 
as well [22]. Enzymatically deglycosylated samples (using N- 
glycosidase F) were also analyzed. The fully glycosylated form 
of GFKARct and GFKARfl  are 45 and 41 kDa, respectively 
(Fig. 3, lane 1 and 3), consistent with previously determined 
apparent molecular mass of native kainate receptor proteins in 
goldfish brain [22]. Fully glycosylated frog KBP is 48 kDa (Fig. 
3, lane 5), consistent with the molecular mass of the native 
protein in frog brain [16]. The glycosylated KBP(S267G) mu- 
tant is smaller than frog KBP, indicating that Ser-267 to Gly 
mutation rendered N265 non-functional nd that N265 is ex- 
tracellular. An increase in mobility of all four preparations was 
observed after treatment with N-glycosidase F. Deglycosylated 
GFKAR0t and GFKARfl  have the same molecular mass (about 
40 kDa), and deglycosylated FKBP and FKBP(S267G) mutant 
have the same molecular mass (about 43 kDa). 
The binding of [3H]kainate to the membrane preparations of
HEK 293 cells transfected with frog KBP or FKBP(S267G) 
mutant was measured (Fig. 4). The Scatchard plots were linear 
for both, with a Ko of 6.6 nM for FKBP and 16 nM for 
FKBP(S267G) mutant. These results indicated that the $267G 
mutation, while eliminating the carbohydrate chain on Asn- 
265, did not significantly affect the proper folding and the 
assembly of the receptor. The slight decrease (approximately 
2.5-fold) in Ko is probably due to the Ser-267 to Gly mutation 
rather than the loss of one carbohydrate chain, since in case of 
GluR3 and GIuR6, this region is directly involved in forming 
the ligand binding pocket [23]. The Ser-267 to Gly mutation 
may have a subtle effect on the structure of the ligand binding 
domain. [3H]Kainate binding is comformationally dependent, 
since denaturation (boiling 1 min) of the receptor preparation 
completely eliminated the [3H]kainate binding activity (data not 
shown). Judging from both immunoblotting and the [3H]ka- 
inate binding, GFKAR~, GFKARfl, FKBP and the 
FKBP(S267G) mutant were all effectively expressed in the 
transfected HEK 293 cells. In each case, the maximum binding 
(Bmax) is in the range of 2-5 × 105 sites per cell. The Ser-267 to 
Gly mutation did not appear affect he expression of the mutant 
FKBP. 
4. Discuss ion 
Asn-265 of frog KBP is a functional native N-glycosylation 
site. Therefore, the sequence surrounding Ash-265 is located 
extracellularly in the mature receptor protein (Fig. 5). This 
result is consistent with recent topological studies on several 
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Fig. 4. Saturation binding analysis of transfected HEK 293 cell mem- 
brane preparations. Untransfected HEK 293 cells have no binding 
activity for [~H]kainate. The curves are the aveIage of triplicates 
(S.E.M. are less than 10%). The Scatehard plots derived from the 
saturation curves are shown in the insert. The K d for [3H]kainate bind- 
ing at equilibrium is6.6 nM for frog KBP and 16 nM for FKBP(S267G) 
mutant. Binding parameters were determined using a non-linear least 
squares fit to the data. The maximum binding (Bmax) corresponded to
approximately 2 to 5 × 105 sites per transfected cell for both wild and 
mutant frog KBPs. 
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Fig. 5. Transmembrane topology (3-TM model) of kainate binding 
proteins. Native functional N-Klycosylation sites in frog KBP and 
GFKARct are shown as ~ and ~, respectively. The previously desig- 
nated TMII region is proposed to dip into the center of the oligomeric 
receptor due to subunit folding and assembly in vivo. 
members of the glutamate receptor family (e.g. GFKARc~, 
GFKARfl [5,9], GluR1 [10] and GluR3 [11]). While the 4-TM 
and 5-TM models [2,24-26] all place this site on the cytoplasmic 
side, only a topology with three TMs [5,9-11] place this site on 
the extracellular side of the plasma membrane. The proposed 
3-TM topology model raises questions concerning the reported 
identification of regulatory phosphorylation sites in iGluR sub- 
units, in particular the PKA sites (Ser-648 and Ser-666, [27,28]) 
and Ca>/calmodulin-dependent ki ase site (Ser-627, [29]) of 
GluR6. 
The sequence of Asn-X-Ser/Thr-Y is a necessary, but not 
sufficient condition lbr the attachment of oligosaccharide 
chains. In order to produce a functional site, the following 
conditions hould also be satisfied: (a) the site has to be translo- 
cated across the membrane of the rough endoplasmic reticulum 
(ER) at the early step of receptor biosynthesis, because oligo- 
saccharidyl transferase is an integral membrane protein located 
in the lumen of ER [30,31]; (b) the consensus site has to be at 
least 12-14 residues away from the lumenal side of ER mem- 
brane [32]; (c) residues X and Y cannot be proline [33]. There- 
fore, N241QTP of frog KBP is not a functional N-glycosylation 
site because both the short distance to the proposed TMIII  
(only 10 residues away) and the presence of the adjacent Pro- 
243 on the C-terminal side of N241QT would render it non- 
functional. Generally, when the above three requirements are 
satisfied, a consensus N-glycosylation site (either native or engi- 
neered by mutagenesis) will be used in the in vitro coupled 
translation/membrane translocation system in the presence of 
microsomes. This makes the in vitro translation/translocation 
system a very useful tool for deducing the transmembrane to- 
pology of membrane proteins, which is a crucial step for under- 
standing the structure-function in the absence of direct three- 
dimensional structure-determination. 
In addition to the in vitro translation/translocation system, 
the N-glycosylation of the proteins expressed in a mammalian 
cell line also lends valuable information to the identification of 
the glycosylation site. Since N-linked oligosaccharide chains 
can affect protein folding [34], an engineered site (introduced 
without proper consideration of 3D structure of the protein) 
upon glycosylation could disrupt he correct folding of nascent 
polypeptide chain in vivo, resulting in the failure of the expres- 
sion of the mutated protein or the expression of a non-func- 
tional protein in heterologous expression system (e.g. oocytes 
and transfected cell lines). In previous tudies, native and func- 
tional glycosylation sites have been identified in the C-terminal 
half of the large loop between TMIII  and TMIV [5,24,25], and 
mutations adding additional glycosylation sites to the N-termi- 
nal half of this loop have been used to indicate that it too is 
extracellular [5,9,10]. One caveat is that these mutations have 
not been demonstrated to result in a correctly folded protein. 
Thus, the identification of the native site, in particular Asn-265 
of frog KBP, is of particular importance in testing the 3-TM 
model. We demonstrate h re that the frog KBP has a native and 
functional consensus N-glycosylation site (Asn-265) only 35 
residues from TMIII in the N-terminal portion of this loop and 
that, in both the glycosylated and the less glycosylated form of 
the protein, the binding site remains intact. The identification 
of native N-glycosylation sites of GluR6 [24,25] and frog KBP 
in this study also showed that members of the family of iGluRs 
have functional N-glycosylation sites in both the extracellular 
N-terminal and the large loop between TMIII and TMIV, 
which indicates that Ash-linked oligosaccharides are not neces- 
sarily restricted to a single extracellular segment as suggested 
by Landolt-Marticorena and Reithmeier [35]. 
Defining the transmembrane topology is critical for under- 
standing the structure and its relationship to function of 
iGluRs. The 3-TM model has led to a drastically revised view 
of the evolutionary origin and the modular structural design of 
iGluRs [8] in two major respects. (1) The model predicts two 
large extracellular regions (the N-terminal region preceding 
TMI and that between TMIII and TMIV). Interestingly, these 
two regions were found to be homologous to bacterial periplas- 
mic amino acid binding proteins [36,37]. Study of the glycine 
binding site of the NMDA receptor and recent domain-swap- 
ping experiments between GIuR 1 and GluR6 showed that these 
two regions together form the ligand binding pocket [23,38]. 
(2) We found that TMII, the region likely involved in forming 
the channel pore of iGluRs, is homologous to the pore-forming 
P-segment of various K ÷ channels [8]. Therefore, iGluRs are 
likely to have evolved by splicing together several primordial 
structural modules with distinct functions. While the structural 
relationship between these lower molecular weight kainate 
binding proteins (e.g. GFKARc~, GFKARfl, frog KBP and 
chick KBP) and subunits of AMPA and Kainate receptors is 
evident; thus far, ion channel activity has not been demon- 
strated when these KBPs were expressed in heterologous ex- 
pression systems (e.g. oocytes and transfected mammalian 
cells). Therefore, the physiological role of this class of receptor 
proteins remains to be determined. With regard to this impor- 
tant and unsolved issue, it is of interest o note that, although 
GIuR~ shows no ligand binding activity for various glutamater- 
gic ligands and no ion channel activity when expressed in 
heterologous expression system, GIuR~ has significant physio- 
logical importance as indicated by the study of transgenic mice 
with mutations in GluR8 [39]. 
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